Investigation of the effect of selenium on the treatment of patients undergoing coronary artery bypass surgery with a pump

Investigating the effect of high dose of selenium on the Clinical Situation of patients undergoing coronary artery bypass surgery with a pump

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220614055165N1

Enrollment

Registered

2023-07-18

Start date

2023-08-23

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Graft Surgery. Other mechanical complication of coronary artery bypass graft, subsequent encounter

Interventions

Intervention 1: Intervention group: One vial of 500 micrograms of selenium {BIOSYN manufacturer, made in Germany} before anesthesia induction, one vial of 500 micrograms of selenium before transfer to

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: Candidate patients on-pomp with Coronary artery bypass graft surgery

Exclusion criteria

Exclusion criteria: Patients under Off- pomp Coronary artery bypass graft surgery

Design outcomes

Primary

Measure	Time frame
Clinical Situation. Timepoint: Before the start of the intervention, during the intervention. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMoahmmad Saeidi

Ghoum University of Medical Sciences

dr.msaeidi@hotmail.com+98 25 3612 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026